| Literature DB >> 33235480 |
Liyun He1, Na Yang1, Fan Ping1, Lingling Xu1, Wei Li1, Yuxiu Li1, Huabing Zhang1.
Abstract
PURPOSE: High-sensitivity C-reactive protein (hs-CRP) has been shown as an important predictor of cardiovascular risk, and sleep duration is an important factor influencing health outcomes. However, the association between hs-CRP and sleep duration among Chinese adults remained unknown and controversial. We aimed to explore the associations between sleep duration and hs-CRP levels among Chinese adults, and the differences in sex and geographical regions.Entities:
Keywords: Chinese population; cardiovascular risk; high-sensitivity C-reactive protein; sleep duration
Year: 2020 PMID: 33235480 PMCID: PMC7680170 DOI: 10.2147/DMSO.S265465
Source DB: PubMed Journal: Diabetes Metab Syndr Obes ISSN: 1178-7007 Impact factor: 3.168
Characteristics of Participants Across Sleep Duration
| ≤6h | 7h | 8h(Mean) | ≥9h | P Valuea | Total | |
|---|---|---|---|---|---|---|
| 57.1±13.9 | 51.4±13.7 | 47.8±14.1 | 50.4±17.0 | <0.0001 | 50.0±14.9 | |
| 459(55.2%) | 842(53.5%) | 2082(53.5%) | 986(52.7%) | 0.6852 | 4369(53.5%) | |
| 23.5±3.5 | 23.6±3.5 | 23.4±3.4 | 23.1±3.4 | 0.0002 | 23.4±3.4 | |
| 461(55.5%) | 958(60.8%) | 2699(69.3%) | 1327(70.9%) | <0.0001 | 5445(66.6%) | |
| <0.0001 | ||||||
| Low (n, %) | 655(78.7%) | 1118(71.0%) | 2871(73.7%) | 1551(82.9%) | 6195(75.8%) | |
| Medium (n, %) | 143(17.2%) | 348(22.1%) | 795(20.4%) | 266(14.2%) | 1522(19.0%) | |
| High (n, %) | 33(4.1%) | 109(6.9%) | 227(5.9%) | 54(2.9%) | 423(5.2%) | |
| <0.0001 | ||||||
| Low (n, %) | 55(6.71%) | 117(7.5%) | 359(9.3%) | 211(11.4%) | 742(9.2%) | |
| Medium (n, %) | 275(33.5%) | 491(31.5%) | 1354(35.1%) | 714(38.7%) | 2834(25.1%) | |
| High (n, %) | 490(59.8%) | 951(61.0%) | 2147(55.6%) | 919(49.8%) | 4507(55.7%) | |
| <0.0001 | ||||||
| Northern region (n, %) | 406(48.9%) | 702(44.6%) | 1692(43.5%) | 687(36.7%) | 3847(42.7%) | |
| Southern region (n, %) | 425(51.4%) | 873(55.4%) | 2201(56.5%) | 1184(63.3%) | 4683(57.3%) | |
| 2030.6±717.3 | 2134.8±652.1 | 2162.7±641.5 | 2122.8±686.8 | <0.0001 | 2134.8±665.9 | |
| 255(30.7%) | 421(26.7%) | 1054(27.1%) | 506(27.0%) | 0.1583 | 2236(27.4%) | |
| 285(34.3%) | 543(34.5%) | 1280(32.9%) | 577(30.8%) | 0.1066 | 2685(32.9%) | |
| <0.0001 | ||||||
| Low (n, %) | 528(62.5%) | 901(57.2%) | 1944(49.9%) | 963(51.5%) | 4336(53.1%) | |
| Moderate (%) | 103(12.4%) | 244(15.5%) | 594(15.3%) | 238(12.7%) | 1179(14.4%) | |
| High (n, %) | 200(24.0%) | 430(27.3%) | 1455(34.8%) | 670(35.8%) | 2655(36.5%) | |
| Diabetes (n, %) | 35(4.2%) | 46(2.9%) | 92(2.4%) | 60(3.2%) | 0.0205 | 233(2.9%) |
| Hypertension (%) | 170(20.5%) | 210(13.3%) | 405(10.4%) | 271(14.5%) | <0.0001 | 1056(12.9%) |
| MI (n, %) | 13(1.6%) | 20(1.3%) | 23(0.6%) | 22(1.2%) | 0.0100 | 78(1.0%) |
| Stroke (n, %) | 17(2.0%) | 11(0.7%) | 39(1.0%) | 39(2.1%) | 0.0002 | 106(1.3%) |
| SBP (mmHg) | 130.5±20.8 | 125.7±18.9 | 123.0±17.8 | 124.0±20.0 | <0.0001 | 124.7±19.0 |
| DBP (mmHg) | 82.7±11.5 | 81.0±11.4 | 80.2±11.0 | 79.6±11.5 | <0.0001 | 80.5±11.3 |
| 1.80±1.88 | 1.70±1.88 | 1.55±1.74 | 1.73±1.90 | <0.0001 | 1.64±1.82 | |
| 1.78±1.46 | 1.67±1.52 | 1.68±1.52 | 1.66±1.46 | 0.0278 | 1.68±1.50 | |
| 3.11±0.97 | 3.03±0.97 | 2.95±0.99 | 2.92±0.95 | <0.0001 | 2.97±0.98 | |
| 1.45±0.39 | 1.44±0.49 | 1.44±0.55 | 1.43±0.43 | 0.2854 | 1.44±0.50 | |
| 316.5±98.5 | 306.8±110.9 | 306.8±105.0 | 307.9±110.1 | 0.0408 | 308.1±106.7 | |
| 5.51±1.50 | 5.37±1.34 | 5.30±1.38 | 5.33±1.47 | <0.0001 | 5.34±1.41 | |
| 14.91±28.31 | 13.78±19.04 | 14.17±21.58 | 14.89±26.44 | 0.1055 | 14.33±23.10 |
Notes: Data are expressed as the mean ± SD or as number (percentage). aP value represents the significance of difference across sleep duration categories. P values were determined by one-way analysis of variance or Kruskal–Wallis test for continuous variables and Pearson χ2 statistic for categorical variables.
Abbreviations: BMI, body mass index; MI, Myocardial infarction; SBP, systolic blood pressure; DBP, diastolic blood pressure; hs-CRP, high sensitive C-reactive protein; TG, triglycerides; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; UA, uric acid. Glucose: Fasting serum glucose. Insulin: Fasting serum insulin.
Characteristics of Participants by Sex and Geographical Region
| Male | Female | P Valuea | Northern | Southern | P Valuea | |
|---|---|---|---|---|---|---|
| 8.0±1.2 | 7.9±1.2 | 0.3070 | 7.8±1.2 | 8.0±1.2 | <0.0001 | |
| Sleep duration ≤ 6h | 372(9.8%) | 459(10.5%) | 406(11.7%) | 425(9.1%) | ||
| Sleep duration = 7h | 733(19.3%) | 842(19.3%) | 702(20.1%) | 873(18.6%) | ||
| Sleep duration = 8h | 1811(47.7%) | 2082(47.7%) | 1692(48.5%) | 2201(47.0%) | ||
| Sleep duration ≥ 9h | 885(22.6%) | 986(23.3%) | 687(19.7%) | 1184(25.3%) | ||
| 50.0±15.0 | 50.1±15.0 | 0.9800 | 49.7±15.5 | 50.3±15.3 | 0.0814 | |
| 23.4±3.4 | 23.4±3.5 | 0.8410 | 24.1±3.4 | 22.8±3.3 | <0.0001 | |
| 2537(66.7%) | 2908(66.6%) | 0.8692 | 2385(68.4%) | 3060(65.3%) | 0.0038 | |
| 0.0041 | 0.0115 | |||||
| Low (n, %) | 312(8.3%) | 430(10.0%) | 350(10.1%) | 392(8.5%) | ||
| Medium (n, %) | 1293(34.3%) | 1541(35.7%) | 1168(33.7%) | 1666(36.1%) | ||
| High (n, %) | 2165(57.4%) | 2342(54.3%) | 1945(56.2%) | 2562(55.4%) | ||
| <0.0001 | 0.0220 | |||||
| Low (n, %) | 2712(71.4%) | 3483(79.7%) | 2619(75.1%) | 3576(76.3%) | ||
| Medium (n, %) | 830(21.8%) | 722(16.5%) | 660(18.9%) | 892(19.0%) | ||
| High (n, %) | 259(6.8%) | 167(3.8%) | 208(6.0%) | 215(4.6%) | ||
| 2338.0±669.7 | 1957.9 ±609.9 | <0.0001 | 2075.1±623.4 | 2179.2±692.6 | <0.0001 | |
| 2079(54.7%) | 157(3.6%) | <0.0001 | 938(26.9%) | 1298(27.7%) | 0.4124 | |
| 2294(60.3%) | 391(9.0%) | <0.0001 | 1145(32.8%) | 1540(32.9%) | 0.9631 | |
| <0.0001 | <0.0001 | |||||
| Low (n, %) | 1767(46.5%) | 2569(58.8%) | 1841(52.8%) | 2495(53.3%) | ||
| Moderate (n, %) | 648(17.0%) | 531(12.1%) | 446(12.8%) | 733(15.6%) | ||
| High (n, %) | 1386(36.5%) | 1269(29.1%) | 1200(34.4%) | 1455(31.1%) | ||
| Diabetes (n, %) | 125(3.3%) | 108(2.5%) | 0.0270 | 123(3.5%) | 110(2.4%) | 0.0015 |
| Hypertension (n, %) | 466(12.3%) | 590(13.5%) | 0.0945 | 462(13.2%) | 594(12.7%) | 0.4515 |
| MI (n, %) | 38(1.0%) | 40(0.9%) | 0.6963 | 46(0.5%) | 32(0.4%) | 0.0035 |
| Stroke (n, %) | 74(1.9%) | 32(0.7%) | <0.0001 | 56(1.6%) | 50(1.1%) | 0.0335 |
| SBP (mmHg) | 126.1±17.5 | 123.4±20.1 | <0.0001 | 126.3±18.0 | 123.5±19.4 | <0.0001 |
| DBP (mmHg) | 82.1±11.0 | 79.0±11.3 | <0.0001 | 82.8±11.1 | 78.7±11.1 | <0.0001 |
| 1.68±1.81 | 1.62±1.84 | 0.0007 | 1.65±1.80 | 1.64±1.85 | 0.1696 | |
| 1.83±1.74 | 1.56±1.25 | <0.0001 | 1.75±1.66 | 1.64±1.37 | 0.0191 | |
| 2.92±0.96 | 3.02±0.98 | <0.0001 | 3.04±1.03 | 2.92±0.93 | <0.0001 | |
| 1.39±0.53 | 1.48±0.47 | <0.0001 | 1.42±0.56 | 1.45±0.45 | <0.0001 | |
| 356.8±113.0 | 265.7±79.6 | <0.0001 | 292.3±107.1 | 319.8±105.0 | <0.0001 | |
| 5.41±1.54 | 5.28±1.27 | 0.0071 | 5.50±1.56 | 5.22±1.26 | <0.0001 | |
| 14.7±23.7 | 14.0±22.5 | 0.2633 | 15.0±22.5 | 13.8±24.5 | <0.0001 |
Notes: Data are expressed as the mean ± SD or as number (percentage). aP value represents the significance of group differences. P values were determined by 2-side t-test for continuous variables and Pearson χ2 statistic for categorical variables.
Abbreviations: BMI, body mass index; MI, myocardial infarction; SBP, systolic blood pressure; DBP, diastolic blood pressure; hs-CRP, high sensitive C-reactive protein; TG, triglycerides; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; UA, uric acid. Glucose: Fasting serum glucose. Insulin: Fasting serum insulin.
Associations Between Sleep Duration and Hs-CRP Levels in the Complete Samples
| Model | ≤6h | 7h | 8h | ≥9h | ||||
|---|---|---|---|---|---|---|---|---|
| β(95% CI) | P value | β(95% CI) | P values | [Reference] | β(95% CI) | P value | ||
| Participants, No. | 831 | 1575 | 3893 | 1871 | ||||
| 0.0957(0.0506, 0.1408) | <0.0001 | 0.0451(0.0098, 0.0803) | 0.0122 | [Reference] | 0.0524(0.0192, 0.0856) | 0.0020 | ||
| Model 1a | 0.0139(−0.0291, 0.0570) | 0.5258 | 0.0064(−0.0268, 0.0397) | 0.7051 | [Reference] | 0.0444(0.0131, 0.0757) | 0.0054 | |
| Model 2 b | 0.0153(−0.0281, 0.0588) | 0.4896 | 0.0093(−0.0242, 0.0428) | 0.5859 | [Reference] | 0.0421(0.0105, 0.0737) | 0.0090 | |
| Model 3c | 0.0094(−0.0341, 0.0528) | 0.6722 | 0.0080(−0.0254, 0.0414) | 0.6388 | [Reference] | 0.0396(0.0082, 0.0709) | 0.0134 | |
| Model 4d | −0.0044(−0.0466, 0.0379) | 0.8396 | 0.0081(−0.0224, 0.0406) | 0.6247 | [Reference] | 0.0369(0.0062, 0.0676) | 0.0183 | |
| Model 5e | −0.0049(−0.0472, 0.0373) | 0.8194 | 0.084(−0.0241, 0.0409) | 0.6113 | [Reference] | 0.0356(0.0050, 0.0663) | 0.0228 | |
Notes: Hs-CRP was normalized by natural-log transformation; the level of hs-CRP at eight hours of sleep was used as a reference. β (95% CI): Regression coefficients and 95% confidence interval of log hs-CRP across sleep duration categories. aModel 1 adjusted for age, sex, body mass index (BMI). bModel 2 adjusted for Model 1, educational attainment, geographical region, residence and household income per capita. cModel 3 adjusted for Model 2, smoking status, alcohol drinking habits, physical activities levels and total energy intake. dModel 4 adjusted for Model 3, systolic and diastolic blood pressure, low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), triglycerides, uric acid, fasting serum glucose, fasting serum insulin. eModel 5: adjusted for Model 4 and health status related variables (the histories of diagnosed diabetes, hypertension, myocardial infarction, stroke and cancer, the uses of oral antidiabetic medicines, insulin, and antihypertensive drugs).
Abbreviations: CI, confidence interval; hs-CRP, high-sensitivity C-reactive protein.
Relationships Between Sleep Duration and Hs-CRP Levels by Sex
| Model | ≤6h | 7h | 8h | ≥9h | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| β(95% CI) | P value | β(95% CI) | P value | [Reference] | β(95% CI) | P value | |||||||
| Participants, No. | 372 | 733 | 1811 | 885 | |||||||||
| 0.0500(−0.0157, 0.1157) | 0.1357 | 0.0386(−0.0119, 0.0892) | 0.1338 | [Reference] | 0.0332(−0.0142, 0.0805) | 0.1695 | |||||||
| Model 1a | 0.0024(−0.0616, 0.0663) | 0.9424 | 0.0134(−0.0355, 0.0622) | 0.5916 | [Reference] | 0.0297(−0.0160, 0.0755) | 0.2028 | ||||||
| Model 2 b | 0.0051(−0.0592, 0.0695) | 0.8757 | 0.0148(−0.0342, 0.0637) | 0.5548 | [Reference] | 0.0277(−0.0182, 0.0736) | 0.2371 | ||||||
| Model 3c | 0.0017(−0.0625, 0.0659) | 0.9592 | 0.0148(−0.0340, 0.0637) | 0.5519 | [Reference] | 0.0258(−0.0200, 0.0716) | 0.2690 | ||||||
| Model 4d | −0.0006(−0.0626, 0.0638) | 0.9851 | 0.0173(−0.0308, 0.0653) | 0.4817 | [Reference] | 0.0227(−0.0224, 0.0678) | 0.3238 | ||||||
| Model 5e | −0.0006(−0.0637, 0.0625) | 0.9843 | 0.0200(−0.0281, 0.0681) | 0.4148 | [Reference] | 0.0214(−0.0238, 0.0666) | 0.3530 | ||||||
| Participants, No. | 459 | 842 | 2082 | 986 | |||||||||
| 0.1346(0.0726, 0.1966) | <0.001 | 0.0507(0.0016, 0.0997) | 0.0431 | [Reference] | 0.0688(0.0224, 0.1153) | 0.0037 | |||||||
| Model 1a | 0.0180(−0.0401, 0.0762) | 0.5433 | −0.0008(−0.0461, 0.0445) | 0.9731 | [Reference] | 0.0564(0.0136, 0.0992) | 0.0097 | ||||||
| Model 2 b | 0.0218(−0.0365, 0.0801) | 0.4644 | −0.0013(−0.0466, 0.0440) | 0.9545 | [Reference] | 0.0549(0.0120, 0.0978) | 0.0122 | ||||||
| Model 3c | 0.0159(−0.0426, 0.0743) | 0.5941 | −0.0040(−0.0492, 0.0412) | 0.8619 | [Reference] | 0.0525(0.0096, 0.0953) | 0.0163 | ||||||
| Model 4d | −0.0102(−0.0667, 0.0463) | 0.7232 | 0.0043(−0.0394, 0.0479) | 0.8487 | [Reference] | 0.0517(0.0104, 0.0931) | 0.0142 | ||||||
| Model 5e | −0.0087(−0.0654, 0.0479) | 0.7626 | 0.0018(−0.0420, 0.0456) | 0.9355 | [Reference] | 0.0512(0.0097, 0.0927) | 0.0155 | ||||||
Notes: Hs-CRP was normalized by natural-log transformation; the level of hs-CRP at eight hours of sleep was used as a reference. β (95% CI): Regression coefficients and 95% confidence interval of log hs-CRP across sleep duration categories. aModel 1 adjusted for age, body mass index (BMI). bModel 2 adjusted for Model 1, educational attainment, geographical region, residence and household income per capita. cModel 3 adjusted for Model 2, smoking status, alcohol drinking habits, physical activities levels and total energy intake. dModel 4 adjusted for Model 3, systolic and diastolic blood pressure, low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), triglycerides (TG), uric acid (UA), fasting serum glucose, fasting serum insulin. eModel 5: adjusted for Model 4 and health status related variables (the histories of diagnosed diabetes, hypertension, myocardial infarction, stroke and cancer, the uses of oral antidiabetic medicines, insulin, and antihypertensive drugs).
Abbreviations: CI, confidence interval; hs-CRP, high-sensitivity C-reactive protein.
Relationships Between Sleep Duration and Hs-CRP Levels by Geographical Region
| Model | ≤6h | 7h | 8h | ≥9h | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| β(95% CI) | P value | β(95% CI) | P value | [Reference] | β(95% CI) | P value | ||||
| Participants, No. | 425 | 873 | 2201 | 1184 | ||||||
| 0.1067(0.0432, 0.1703) | 0.0010 | 0.0421(−0.0059, 0.0901) | 0.0853 | [Reference] | 0.0417(−0.0015, 0.0849) | 0.0586 | ||||
| Model 1a | 0.0018(−0.0583, 0.0620) | 0.9523 | −0.0032(−0.0480, 0.0417) | 0.8902 | [Reference] | 0.0207(−0.0197, 0.0611) | 0.3154 | |||
| Model 2 b | 0.0038(−0.0566, 0.0641) | 0.9025 | −0.0020(−0.0470, 0.0429) | 0.9292 | [Reference] | 0.0197(−0.0208, 0.0602) | 0.3407 | |||
| Model 3c | −0.0009(−0.0612, 0.0593) | 0.9755 | −0.0035(−0.0483, 0.0413) | 0.8792 | [Reference] | 0.0210(−0.0194, 0.0613) | 0.3090 | |||
| Model 4d | −0.0105(−0.0694, 0.0484) | 0.7279 | −0.0032(−0.04692, 0.0406) | 0.8872 | [Reference] | 0.0173(−0.0222, 0.0568) | 0.3839 | |||
| Model 5e | −0.0107(−0.0696, 0.0482) | 0.7695 | −0.0041(−0.0479, 0.0398) | 0.8559 | [Reference] | 0.0166(−0.0229, 0.0561) | 0.4098 | |||
| Participants, No. | 406 | 702 | 1692 | 687 | ||||||
| 0.0827(0.0189, 0.1465) | 0.0111 | 0.0484(−0.0034, 0.1003) | 0.0671 | [Reference] | 0.0733(0.0211, 0.1256) | 0.0029 | ||||
| Model 1a | 0.0301(−0.0317, 0.0918) | 0.3402 | 0.0181(−0.0314, 0.0675) | 04738 | [Reference] | 0.0749(0.0253, 0.1245) | 0.0031 | |||
| Model 2 b | 0.0293(−0.0328, 0.0914) | 0.3550 | 0.0164(−0.0333, 0.0661) | 0.5173 | [Reference] | 0.0745(0.0246, 0.1244) | 0.0034 | |||
| Model 3c | 0.0210(−0.0412, 0.0831) | 0.5091 | 0.0156(−0.0340, 0.0629) | 0.5705 | [Reference] | 0.0715(0.0216, 0.1215) | 0.0050 | |||
| Model 4d | 0.0036(−0.0572, 0.0644) | 0.9086 | 0.0200(−0.0284, 0.0684) | 0.4187 | [Reference] | 0.0717(0.0229, 0.1205) | 0.0040 | |||
| Model 5e | 0.0034(−0.0574, 0.0642) | 0.9120 | 0.0210(−0.0274, 0.0695) | 0.3953 | [Reference] | 0.0699(0.0210, 0.1187) | 0.0051 | |||
Notes: Hs-CRP was normalized by natural-log transformation; the level of hs-CRP at eight hours of sleep was used as a reference. β (95% CI): Regression coefficients and 95% confidence interval of log hs-CRP across sleep duration categories. aModel 1 adjusted for age, sex, body mass index (BMI). bModel 2 adjusted for Model 1, educational attainment, residence and household income per capita. cModel 3 adjusted for Model 2, smoking status, alcohol drinking habits, physical activities levels and total energy intake. dModel 4 adjusted for Model 3, systolic and diastolic blood pressure, low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), triglycerides (TG), uric acid (UA), fasting serum glucose, fasting serum insulin. eModel 5: adjusted for Model 4 and health status related variables (the histories of diagnosed diabetes, hypertension, myocardial infarction, stroke and cancer, the uses of oral antidiabetic medicines, insulin, and antihypertensive drugs).
Abbreviations: CI, confidence interval; hs-CRP, high-sensitivity C-reactive protein.